Key result
ACC/AHA cholesterol guidelines emphasize shared decision-making for primary prevention statin initiation.
Answers are grounded in this paper and cite their sources.
AHA) issued clinical guidelines on cardiovascular disease risk assessment (1) and cholesterol treatment (2). The rec-ommendations are intended to guide decision making but do not replace clinical judgment. We highlight the core concepts of the guidelines that rest on widespread consen-sus, discuss controversial aspects, and suggest a potential middle ground for clinicians and patients struggling with how to proceed in the midst of the controversy. CORE CONCEPTS Value of the Art of Medicine The new guidelines value the art of medicine in that they allow room for individualizing primary prevention on the basis of shared decision making between the patient and clinician. When one is considering whether to initiate a statin for primary prevention in adults with a low-density
No takes yet. Share an insight, caveat, or question.
Martin et al. (2014) conducted a review in Cardiovascular disease risk assessment and cholesterol treatment. 2013 ACC/AHA Risk Assessment and Cholesterol Treatment Guidelines was evaluated. The 2013 ACC/AHA cholesterol guidelines emphasize shared decision-making for primary prevention statin initiation, though no quantitative trial outcomes are reported in this review.
Synapse has enriched 10 related papers. Consider them for comparative context: